trandate filmuhúðuð tafla 200 mg
aspen pharma trading limited - labetalolum hýdróklóríð - filmuhúðuð tafla - 200 mg
xylocain hlaup 20 mg/g
aspen pharma trading limited - lidocainum hýdróklóríð - hlaup - 20 mg/g
xylocain húðúði, lausn 100 mg/ml
aspen pharma trading limited - lidocainum inn - húðúði, lausn - 100 mg/ml
xylocain stungulyf, lausn 10 mg/ml
aspen pharma trading limited - lidocainum hýdróklóríð - stungulyf, lausn - 10 mg/ml
xylocain stungulyf, lausn 20 mg/ml
aspen pharma trading limited - lidocainum hýdróklóríð - stungulyf, lausn - 20 mg/ml
xylocain ukonserveret (xylocain án rotvarnarefna) hlaup 20 mg/ml
aspen pharma trading limited - lidocainum hýdróklóríð - hlaup - 20 mg/ml
pentocur (tiopental abcur) stungulyfsstofn, lausn 1 g
abcur ab - thiopentalum natricum inn - stungulyfsstofn, lausn - 1 g
circomax myco
zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - Ónæmissjúkdómar fyrir suidae - svín (fyrir fitandi) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection. onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination. duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination. in addition, vaccination has been shown to reduce body weight gain losses under field conditions.
emla krem 25+25 mg/g
aspen pharma trading limited - lidocainum inn; prilocainum inn - krem - 25+25 mg/g
eusaprim mixtúra, dreifa 8 mg/ml+40 mg/ml
aspen pharma trading limited - sulfamethoxazolum inn; trimethoprimum inn - mixtúra, dreifa - 8 mg/ml+40 mg/ml